Funding Opportunities

This is a listing of Requests for Applications (RFA), Program Announcements (PA), and Notices specific to the group's key programs.

Standard submission dates apply for all listings, unless otherwise noted.

Guidance For Investigators Planning to Submit a Program Project Grant (P01)

Notice: Internet links not permitted in NIH Grant Applications

Information about the funding opportunity announcements that align with the efforts of the Cancer MoonshotSM can be found here: https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/funding.

Title Announcement # Expiration Date Research Focus
Administrative Supplement for Research on Dietary Supplements (Admin Supp-Clinical Trial Not Allowed) PA-20-227 04/16/2023
    • Nutritional Science
Advancing Mechanistic Probiotic/Prebiotic and Human Microbiome Research PA-18-876 (R01 Clinical Trial Not Allowed) 09/08/2021
    • Nutritional Science
Advancing Translational and Clinical Probiotic/Prebiotic and Human Microbiome Research PA-18-902 (R01 Clinical Trial Optional) 09/08/2021
    • Cancer Biomarkers
Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression PA-18-739 (R21 Clinical Trial Optional) 05/08/2021
    • Nutritional Science
Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression PA-18-738 (R01 Clinical Trial Optional) 05/08/2021
    • Nutritional Science
Basic and Translational Research on Adducts in Cancer Risk Identification and Prevention PAR-19-252 (R21 Clinical Trial Optional) 11/09/2021
    • Adductomics Research Program
    • Cancer Biomarkers
Basic and Translational Research on Adducts in Cancer Risk Identification and Prevention PAR-19-251 (R01 Clinical Trial Optional) 11/09/2021
    • Adductomics Research Program
    • Cancer Biomarkers
Biology of Bladder Cancer PAR-19-183 (R01 Clinical Trial Optional) 05/08/2022
    • Prostate and Urologic Cancer
Biology of Bladder Cancer PAR-19-184 (R21 Clinical Trial Optional) 05/08/2022
    • Prostate and Urologic Cancer
Biology of Lung, and Head and Neck Preneoplasias PA-17-460 (R21 - Clinical Trial Not Allowed) 01/08/2021
    • Lung and Upper Aerodigestive Cancer
Biology of Lung, and Head and Neck Preneoplasias PA-17-459 (R01) 01/08/2021
    • Lung and Upper Aerodigestive Cancer
Cancer Prevention and Control Clinical Trials Grant Program PAR-21-035 (R01 Clinical Trial Required) 01/08/2024
    • Breast and Gynecologic Cancer
Cancer Prevention and Control Clinical Trials Grant Program PAR-18-559 (R01 Clinical Trial Required) 01/08/2021
    • Breast and Gynecologic Cancer
    • Gastrointestinal and Other Cancers
    • Lung and Upper Aerodigestive Cancer
    • Prostate and Urologic Cancer
Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research PAR-19-113 (R01 Clinical Trial Optional) 01/08/2022
    • Cancer Biomarkers
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies PAR-19-325 (R01 Clinical Trial Optional) 02/12/2022
    • Community Oncology and Prevention Trials
Developing the Therapeutic Potential of the Endocannabinoid System for Pain Treatment PA-18-917 (R01 - Clinical Trial Optional) 09/08/2021
    • Supportive Care and Symptom Management
Development of Wearable Smart Devices for Continuous Monitoring of Circulating Nutrients, Metabolites and Hormones (R21/R33 Clinical Trial Required) PAR-20-134 06/09/2021
    • Nutritional Science
Diet and Physical Activity Assessment Methodology PAR-18-857 (R21 Clinical Trial Not Allowed) 09/08/2021
    • Nutritional Science
Diet and Physical Activity Assessment Methodology PA-18-856 (R01 Clinical Trial Not Allowed) 09/08/2021
    • Nutritional Science
Exploratory/Developmental Clinical Research Grants in Obesity PA-18-720 (R21 Clinical Trial Optional) 05/08/2021
    • Nutritional Science
Gastrointestinal (GI) and Microbiome Explorers: Development of Swallowable Smart Pills or Devices for Precision Nutrition, Microbiome and Digestive Disease Applications (R21/R33 Clinical Trial Required) PAR-20-133 06/09/2021
    • Nutritional Science
Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Aggressive Cancer PAR-19-264 (R01 Clinical Trial Optional) 12/11/2021
    • Consortium for Imaging and Biomarkers
    • Cancer Biomarkers
Improving Outcomes in Cancer Treatment-Related Cardiotoxicity PA-19-112 (R01 Clinical Trial Optional) 01/08/2022
    • Supportive Care and Symptom Management
Improving Outcomes in Cancer Treatment-Related Cardiotoxicity PA-19-111 (R21 Clinical Trial Optional) 01/08/2022
    • Supportive Care and Symptom Management
Mechanisms, Models, Measurement, and Management in Pain Research PA-18-159 (R21 Clinical Trial Optional) 05/08/2021
    • Supportive Care and Symptom Management
Mechanisms, Models, Measurement, and Management in Pain Research PA-18-141 (R01 Clinical Trial Optional) 05/08/2021
    • Supportive Care and Symptom Management
Mechanisms Underlying the Contribution of Sleep Disturbances to Pain PA-19-201 (R21 Clinical Trial Optional) 05/08/2022
    • Supportive Care and Symptom Management
Mechanisms Underlying the Contribution of Sleep Disturbances to Pain PA-19-200 (R01 Clinical Trial Optional) 05/08/2022
    • Supportive Care and Symptom Management
Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer PAR-19-199 (R21 Clinical Trial Not Allowed) 11/09/2021
    • Nutritional Science
Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer PAR-19-198 (R01 Clinical Trial Not Allowed) 11/09/2021
    • Nutritional Science
NCI Clinical and Translational Exploratory/Developmental Studies PAR-19-356 (R21 Clinical Trial Optional) 07/21/2022
    • Breast and Gynecologic Cancer
Notice of Correction to Application Types Allowed for PAR-20-053, Program to Assess the Rigor and Reproducibility of Extracellular Vesicle-Derived Analytes for Cancer Detection NOT-CA-20-067 (R01 Clinical Trial Not Allowed) 01/08/2023
    • Cancer Biomarkers
Notice of Extension of the Expiration Date of PAR-18-654 "Basic Research in Cancer Health Disparities" NOT-CA-20-089 (R01 Clinical Trial Not Allowed) 02/09/2021
    • Gastrointestinal and Other Cancers
Notice of Extension of the Expiration Date of PAR-18-655 "Exploratory/Developmental Grants Program for Basic Research in Cancer Health Disparities" NOT-CA-20-090 (R21 Clinical Trial Not Allowed) 02/19/2021
    • Gastrointestinal and Other Cancers
Notice of Information: Contributing to the Global COVID-19 Crisis Response by Allowing Some NCI-supported Projects to be Redirected to COVID-19-related Research During the Crisis NOT-CA-20-054 01/26/2021
    • All DCP Major Programs & Research Groups
Notice of Special Interest (NOSI): Advancing Head and Neck Cancer Early Detection Research (AHEAD) NOT-CA-20-031 01/08/2022
    • Cancer Biomarkers
Notice of Special Interest (NOSI): Single-Cell Proteomics for Interrogating Premalignant and Early Malignant Lesions NOT-CA-20-044 05/08/2023
    • Cancer Biomarkers
Oncology Co-Clinical Imaging Research Resources to Encourage Consensus on Quantitative Imaging Methods and Precision Medicine PAR-18-841 (U24 - Clinical Trial Optional) 06/15/2021
    • Cancer Biomarkers
Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival PAR-18-892 (R21 Clinical Trial Optional) 09/08/2021
    • Nutritional Science
Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival PAR-18-893 (R01 Clinical Trial Optional) 09/08/2021
    • Nutritional Science
Program to Assess the Rigor and Reproducibility of Extracellular Vesicle-Derived Analytes for Cancer Detection PAR-20-053 (R01 Clinical Trial Not Allowed) 01/08/2023
    • Cancer Biomarkers
Promoting Research on Music and Health: Phased Innovation Award for Music Interventions (R61/R33 Clinical Trial Optional) PAR-20-266 06/20/2023
    • Supportive Care and Symptom Management
Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes PAR-20-277 (R21 Clinical Trials Not Allowed) 09/08/2022
    • Cancer Biomarkers
Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes PAR-20-276 (R01 Clinical Trial Not Allowed) 09/08/2022
    • Cancer Biomarkers
Symptom Cluster Characterization in Chronic Conditions PA-17-462 (R01) 01/08/2021
    • Supportive Care and Symptom Management
Symptom Cluster Characterization in Chronic Conditions PA-17-461 (R21) 01/08/2021
    • Supportive Care and Symptom Management
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research PAR-18-913 (U01 Clinical Trial Not Allowed) 08/12/2021
    • Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
    • Early Detection
Validation Studies of Analytical Methods for Dietary Supplement Constituents (Admin Supp - Clinical Trial Not Allowed) PA-20-252 04/16/2022
    • Nutritional Science